Related references
Note: Only part of the references are listed.A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines
Elina O. Erra et al.
CLINICAL INFECTIOUS DISEASES (2012)
Clinical development of IMOJEV®-a recombinant Japanese encephalitis chimeric vaccine (JE-CV)
Mohan Babu Appaiahgari et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Novel approaches to flavivirus drug discovery
Carolyn Botting et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Biological and genetic properties of SA14-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans
Byung-Hak Song et al.
JOURNAL OF MICROBIOLOGY (2012)
Suppressive Effects on the Immune Response and Protective Immunity to a JEV DNA Vaccine by Co-administration of a GM-CSF-Expressing Plasmid in Mice
Hui Chen et al.
PLOS ONE (2012)
Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children
Kenji Okada et al.
VACCINE (2012)
Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)
Akiko Kikukawa et al.
VACCINE (2012)
Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response
Fengjuan Wang et al.
VIROLOGY JOURNAL (2012)
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months Randomized, controlled phase 3 immunogenicity and safety trial
Emmanuel Feroldi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine
Yi-Chin Fan et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
New Japanese encephalitis vaccines: alternatives to production in mouse brain
Scott B. Halstead et al.
EXPERT REVIEW OF VACCINES (2011)
Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype
Manal A. F. Mohammed et al.
INFECTION GENETICS AND EVOLUTION (2011)
Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia
Xiao-Ling Pan et al.
JOURNAL OF VIROLOGY (2011)
Pivotal Role of Antibody and Subsidiary Contribution of CD8+ T Cells to Recovery from Infection in a Murine Model of Japanese Encephalitis
Maximilian Larena et al.
JOURNAL OF VIROLOGY (2011)
Japanese encephalitis virus: from genome to infectome
Salini Krishnan Unni et al.
MICROBES AND INFECTION (2011)
Isolation and Genetic Characteristics of Human Genotype 1 Japanese Encephalitis Virus, China, 2009
Jiu-Song Zhang et al.
PLOS ONE (2011)
Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China
Xinyu Liu et al.
VACCINE (2011)
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51
Susanne Eder et al.
VACCINE (2011)
Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®
Elisabeth Schuller et al.
VACCINE (2011)
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers
Yvonne Van Gessel et al.
VACCINE (2011)
Antibody-mediated neutralization of flaviviruses: A reductionist view
Kimberly A. Dowd et al.
VIROLOGY (2011)
Emergence of Japanese encephalitis virus genotype V in the Republic of Korea
Ratree Takhampunya et al.
VIROLOGY JOURNAL (2011)
Genotype V Japanese Encephalitis Virus Is Emerging
Ming-Hua Li et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Japanese Encephalitis Virus Genotype Replacement, Taiwan, 2009-2010
Yi-Ying Chen et al.
EMERGING INFECTIOUS DISEASES (2011)
Anterior horn cells are also involved in Japanese encephalitis
U. K. Misra et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973-2008
Susan L. Hills et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Strategies for development of dengue virus inhibitors
Christian G. Noble et al.
ANTIVIRAL RESEARCH (2010)
Present and future arboviral threats
Scott C. Weaver et al.
ANTIVIRAL RESEARCH (2010)
Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication
Nai-Yun Hsu et al.
CELL (2010)
Japanese Encephalitis: New Options for Active Immunization
Scott B. Halstead et al.
CLINICAL INFECTIOUS DISEASES (2010)
Japanese encephalitis: update on vaccines and vaccine recommendations
A. Wilder-Smith et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Concomitant or sequential administration of live attenuated japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine Randomized double-blind phase II evaluation of safety and immunogenicity
Peter E. Nasveld et al.
HUMAN VACCINES (2010)
Long-term immunity to live attenuated Japanese encephalitis chimeric virus vaccine Randomized, double-blind, five-year phase II study in healthy adults
Peter E. Nasveld et al.
HUMAN VACCINES (2010)
Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination
Na Gao et al.
IMMUNOLOGY LETTERS (2010)
Genetic characterization of early isolates of Japanese encephalitis virus: genotype II has been circulating since at least 1951
Amy J. Schuh et al.
JOURNAL OF GENERAL VIROLOGY (2010)
An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
Mario Lobigs et al.
JOURNAL OF GENERAL VIROLOGY (2010)
NS1′ of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness
Ezequiel Balmori Melian et al.
JOURNAL OF VIROLOGY (2010)
In Vitro Reconstitution Reveals Key Intermediate States of Trimer Formation by the Dengue Virus Membrane Fusion Protein
Maofu Liao et al.
JOURNAL OF VIROLOGY (2010)
The Endoplasmic Reticulum Provides the Membrane Platform for Biogenesis of the Flavivirus Replication Complex
Leah K. Gillespie et al.
JOURNAL OF VIROLOGY (2010)
Influence of pr-M Cleavage on the Heterogeneity of Extracellular Dengue Virus Particles
Jiraphan Junjhon et al.
JOURNAL OF VIROLOGY (2010)
Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2-to 5-year-olds and Naive 12-to 24-month-olds Multicenter Randomized Controlled Trial
Kulkanya Chokephaibulkit et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Overview: Japanese encephalitis
Usha Kant Misra et al.
PROGRESS IN NEUROBIOLOGY (2010)
Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity
Ronald B. Reisler et al.
VACCINE (2010)
Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
Nicole P. Lindsey et al.
VACCINE (2010)
Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up
Katrin Dubischar-Kastner et al.
VACCINE (2010)
Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
Katrin Dubischar-Kastner et al.
VACCINE (2010)
Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
A. Kaltenboeck et al.
VACCINE (2010)
Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
Joseph Torresi et al.
VACCINE (2010)
Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
Yongxin Yu
VACCINE (2010)
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
Bruno Guy et al.
VACCINE (2010)
Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005
Seok-Min Yun et al.
VIROLOGY JOURNAL (2010)
New Vaccines for Japanese Encephalitis
Scott B. Halstead et al.
Current Infectious Disease Reports (2010)
Molecular Epidemiology of Japanese Encephalitis Virus, Taiwan
Jyh-Hsiung Huang et al.
EMERGING INFECTIOUS DISEASES (2010)
Ecology and Geographical Expansion of Japanese Encephalitis Virus
Andrew F. van den Hurk et al.
ANNUAL REVIEW OF ENTOMOLOGY (2009)
Molecular targets for flavivirus drug discovery
Aruna Sampath et al.
ANTIVIRAL RESEARCH (2009)
Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites
Sonja Welsch et al.
CELL HOST & MICROBE (2009)
Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO (R)]
Sean T. Duggan et al.
DRUGS (2009)
IC51 Japanese Encephalitis vaccine
Herwig Kollaritsch et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Ixiaro®: a new vaccine against Japanese encephalitis
Tomas Jelinek
EXPERT REVIEW OF VACCINES (2009)
Focus on flaviviruses: current and future drug targets
Brian J. Geiss et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures
Shelly J. Robertson et al.
IMMUNOLOGIC RESEARCH (2009)
Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model
S. M. Biswas et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Mechanisms of Evasion of the Type I Interferon Antiviral Response by Flaviviruses
Michael S. Diamond
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Japanese Encephalitis: Defining Risk Incidence for Travelers to Endemic Countries and Vaccine Prescribing From the UK and Switzerland
Christoph Hatz et al.
JOURNAL OF TRAVEL MEDICINE (2009)
Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk
Mads R. Buhl et al.
JOURNAL OF TRAVEL MEDICINE (2009)
Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells
Venkatramana D. Krishna et al.
JOURNAL OF VIROLOGY (2009)
Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fusion
I. -M. Yu et al.
JOURNAL OF VIROLOGY (2009)
3′ cis-Acting Elements That Contribute to the Competence and Efficiency of Japanese Encephalitis Virus Genome Replication: Functional Importance of Sequence Duplications, Deletions, and Substitutions
Sang-Im Yun et al.
JOURNAL OF VIROLOGY (2009)
Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion
Vinod Nayak et al.
JOURNAL OF VIROLOGY (2009)
The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure
Moheshwarnath Issur et al.
RNA (2009)
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
Elisabeth Schuller et al.
VACCINE (2009)
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
A. Kaltenboeck et al.
VACCINE (2009)
Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice
Shailendra Kumar Verma et al.
VACCINE (2009)
A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1′ may derive from ribosomal frameshifting
Andrew E. Firth et al.
VIROLOGY JOURNAL (2009)
Genome cyclization as strategy for flavivirus RNA replication
Sergio M. Villordo et al.
VIRUS RESEARCH (2009)
Past, Present, and Future of Japanese Encephalitis
Tobias E. Erlanger et al.
EMERGING INFECTIOUS DISEASES (2009)
Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines -: Report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies
Morag Ferguson et al.
BIOLOGICALS (2008)
Japanese encephalitis vaccine in travelers
Tomas Jelinek
EXPERT REVIEW OF VACCINES (2008)
Post-vaccination encephalomyelitis: Literature review and illustrative case
William Huynh et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrinmediated endocytosis
Eliana G. Acosta et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine
E. Tauber et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A single N-linked glycosylation site in the Japanese encephalitis virus prM protein is critical for cell type-specific prM protein biogenesis, virus particle release, and pathogenicity in mice
Jeong-Min Kim et al.
JOURNAL OF VIROLOGY (2008)
Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo
Ana P. Goncalvez et al.
JOURNAL OF VIROLOGY (2008)
Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions
Chinmay G. Patkar et al.
JOURNAL OF VIROLOGY (2008)
Role of nonstructural protein NS2A in flavivirus assembly
Jason Y. Leung et al.
JOURNAL OF VIROLOGY (2008)
Viral membrane fusion
Stephen C. Harrison
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication
Byung-Hak Song et al.
RNA (2008)
The flavivirus precursor membrane-envelope protein complex: Structure and maturation
Long Li et al.
SCIENCE (2008)
Structure of the immature dengue virus at low pH primes proteolytic maturation
I-Mei Yu et al.
SCIENCE (2008)
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
Young Mo Sohn et al.
VACCINE (2008)
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
E. Schuller et al.
VACCINE (2008)
Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus
Li Peng et al.
VACCINE (2008)
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
Elisabeth Schuller et al.
VACCINE (2008)
Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT
Clemente Mosso et al.
VIROLOGY (2008)
Dissecting the Cell Entry Pathway of Dengue Virus by Single-Particle Tracking in Living Cells
Hilde M. van der Schaar et al.
PLOS PATHOGENS (2008)
Change in Japanese Encephalitis Virus Distribution, Thailand
Narong Nitatpattana et al.
EMERGING INFECTIOUS DISEASES (2008)
Current use and development of vaccines for Japanese encephalitis
David W. C. Beasley et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
E. Tauber et al.
LANCET (2007)
Japanese encephalitis revisited
Mouhamadou Diagana et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking
Hilde M. van der Schaar et al.
JOURNAL OF VIROLOGY (2007)
Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case-control study in Nepalese children 5 years after immunization
J. B. Tandan et al.
VACCINE (2007)
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
Arthur Lyons et al.
VACCINE (2007)
Characterization of a structural intermediate of flavivirus membrane fusion
Karin Stiasny et al.
PLOS PATHOGENS (2007)
Clinico-laboratory profile and outcome of Japanese encephalitis in Nepali children
Ajit Rayamajhi et al.
ANNALS OF TROPICAL PAEDIATRICS (2006)
Translation of the flavivirus Kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging
Gorben P. Pijlman et al.
JOURNAL OF VIROLOGY (2006)
West nile virus 5′-cap structure is formed by sequential guanine N-7 and ribose 2′-O methylations by nonstructural protein 5
Debashish Ray et al.
JOURNAL OF VIROLOGY (2006)
Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India
Rashmi Kumar et al.
CLINICAL INFECTIOUS DISEASES (2006)
Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells
J. J. H. Chu et al.
VIROLOGY (2006)
Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN
E Pokidysheva et al.
CELL (2006)
West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection
CW Davis et al.
JOURNAL OF VIROLOGY (2006)
Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study
H Ohrr et al.
LANCET (2005)
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses
JL Muñoz-Jordán et al.
JOURNAL OF VIROLOGY (2005)
Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins
WJ Liu et al.
JOURNAL OF VIROLOGY (2005)
West Nile virus inhibits the signal transduction pathway of alpha interferon
JT Guo et al.
JOURNAL OF VIROLOGY (2005)
Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: Infant mice provide an accurate surrogate for the test in monkeys
TP Monath et al.
BIOLOGICALS (2005)
A structural perspective of the Flavivirus life cycle
S Mukhopadhyay et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Solution structure of dengue virus capsid protein reveals another fold
LX Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation
S Bressanelli et al.
EMBO JOURNAL (2004)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway
JJH Chu et al.
JOURNAL OF VIROLOGY (2004)
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
DWC Beasley et al.
VACCINE (2004)
Conformational changes of the flavivirus E glycoprotein
Y Zhang et al.
STRUCTURE (2004)
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
JS Mackenzie et al.
NATURE MEDICINE (2004)
West nile virus core protein: Tetramer structure and ribbon formation
T Dokland et al.
STRUCTURE (2004)
Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia
PT Nga et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Transmission cycles, host range, evolution and emergence of arboviral disease
SC Weaver et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Aluminium compounds for use in vaccines
EB Lindblad
IMMUNOLOGY AND CELL BIOLOGY (2004)
Inhibition of interferon signaling by dengue virus
JL Muñoz-Jordán et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Structure of West Nile virus
S Mukhopadhyay et al.
SCIENCE (2003)
Molecular characterization of the full-length genome of the Japanese encephalitis viral strain K87P39
SI Yun et al.
VIRUS RESEARCH (2003)
Transmission of West Nile virus through blood transfusion in the United States in 2002
LN Pealer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Development of a recombinant vaccine against Japanese encephalitis
R Kaur et al.
JOURNAL OF NEUROVIROLOGY (2003)
Involvement of lipids in different steps of the flavivirus fusion mechanism
K Stiasny et al.
JOURNAL OF VIROLOGY (2003)
Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses
E Navarro-Sanchez et al.
EMBO REPORTS (2003)
Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication
WJ Liu et al.
JOURNAL OF VIROLOGY (2003)
Structures of immature flavivirus particles
Y Zhang et al.
EMBO JOURNAL (2003)
Development and application of a reverse genetics system for Japanese encephalitis virus
SI Yun et al.
JOURNAL OF VIROLOGY (2003)
Transmission of West Nile virus from an organ donor to four transplant recipients
M Iwamoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
B Tassaneetrithep et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial
T Solomon et al.
LANCET (2003)
Origin and evolution of Japanese encephalitis virus in southeast Asia
T Solomon et al.
JOURNAL OF VIROLOGY (2003)
A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge
M Saini et al.
JOURNAL OF VIROLOGY (2003)
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
W Zhang et al.
NATURE STRUCTURAL BIOLOGY (2003)
Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus
S Elshuber et al.
JOURNAL OF GENERAL VIROLOGY (2003)
5 '- and 3 '-noncoding regions in flavivirus RNA
L Markoff
FLAVIVIRUSES: STRUCTURE, REPLICATION AND EVOLUTION (2003)
Allergic reactions to Japanese encephalitis vaccine
AM Plesner
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Japanese encephalitis vaccine for travelers: Exploring the limits of risk
DR Shlim et al.
CLINICAL INFECTIOUS DISEASES (2002)
An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5:: crystal structure and functional characterization
MP Egloff et al.
EMBO JOURNAL (2002)
Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum
IC Lorenz et al.
JOURNAL OF VIROLOGY (2002)
Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis
T Solomon et al.
BRAIN (2002)
Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray valley encephalitis virus
E Lee et al.
JOURNAL OF VIROLOGY (2002)
Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles
BM Kümmerer et al.
JOURNAL OF VIROLOGY (2002)
Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH
K Stiasny et al.
JOURNAL OF VIROLOGY (2002)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Clinical and immunological risk factors for severe disease in Japanese encephalitis
DH Libraty et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2002)
Plasmid DNA immunization against Japanese encephalitis virus: Immunogenicity of membrane-anchored and secretory envelope protein
R Kaur et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase
M Ackermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Seizures in Japanese encephalitis
UK Misra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study
MB Bista et al.
LANCET (2001)
A purified inactivated Japanese encephalitis virus vaccine made in vero cells
AK Srivastava et al.
VACCINE (2001)
Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12-expressing plasmid
HW Chen et al.
JOURNAL OF IMMUNOLOGY (2001)
Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines
M Sakaguchi et al.
ALLERGY (2001)
Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles
E Konishi et al.
JOURNAL OF VIROLOGY (2001)
Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)
J Arroyo et al.
JOURNAL OF VIROLOGY (2001)
Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans
N Kanesa-thasan et al.
VACCINE (2000)
Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain
DT Williams et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States
H Takahashi et al.
VACCINE (2000)
Improving vaccine performance with adjuvants
FR Vogel
CLINICAL INFECTIOUS DISEASES (2000)
Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains
I Kurane et al.
VACCINE (2000)
Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus
SA Tsarev et al.
VACCINE (2000)
Case-control study of allergic reactions to Japanese encephalitis vaccine
AM Plesner et al.
VACCINE (2000)
A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice
GJJ Chang et al.
JOURNAL OF VIROLOGY (2000)
Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system
J Corver et al.
VIROLOGY (2000)
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
TP Monath et al.
JOURNAL OF VIROLOGY (2000)
Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine
E Konishi et al.
VIROLOGY (2000)
Share Paper
